These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20728783

  • 21. [Therapy for peptic ulcer disease].
    Lukáš M.
    Vnitr Lek; 2018; 64(6):595-599. PubMed ID: 30223656
    [Abstract] [Full Text] [Related]

  • 22. Refractory gastrooesophageal reflux disease.
    Bredenoord AJ, Smout AJ.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
    [Abstract] [Full Text] [Related]

  • 23. Proton pump inhibitors: the beginning of the end or the end of the beginning?
    Scarpignato C, Hunt RH.
    Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
    [Abstract] [Full Text] [Related]

  • 24. Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
    Sanders SW.
    Clin Ther; 1996 Dec; 18(1):2-34; discussion 1. PubMed ID: 8851451
    [Abstract] [Full Text] [Related]

  • 25. [New trends of acid-related diseases treatment].
    Koike T, Nakagawa K, Kanno T, Iijima K, Shimosegawa T.
    Nihon Rinsho; 2015 Jul; 73(7):1136-46. PubMed ID: 26165070
    [Abstract] [Full Text] [Related]

  • 26. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E.
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [Abstract] [Full Text] [Related]

  • 27. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
    Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.
    Yale J Biol Med; 1999 Jan; 72(2-3):211-8. PubMed ID: 10780583
    [Abstract] [Full Text] [Related]

  • 28. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N, Matsukawa J, Sakurai Y, Otake K.
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [Abstract] [Full Text] [Related]

  • 29. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
    Bursey F, Crowley M, Janes C, Turner CJ.
    CMAJ; 2000 Mar 21; 162(6):817-23. PubMed ID: 10750472
    [Abstract] [Full Text] [Related]

  • 30. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AP, Jagtap JR, Bhosale AV.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1181-205. PubMed ID: 17150362
    [Abstract] [Full Text] [Related]

  • 31. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B, McColl K.
    Aliment Pharmacol Ther; 2005 Aug 01; 22 Suppl 1():32-40. PubMed ID: 16042657
    [Abstract] [Full Text] [Related]

  • 32. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A, Peitz U, Malfertheiner P.
    Wien Med Wochenschr; 2001 Aug 01; 151(13-14):300-8. PubMed ID: 11582994
    [Abstract] [Full Text] [Related]

  • 33. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Yang X, Li Y, Sun Y, Zhang M, Guo C, Mirza IA, Li YQ.
    Dig Dis Sci; 2018 Feb 01; 63(2):302-311. PubMed ID: 29282636
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
    Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim HJ, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS.
    Dig Liver Dis; 2009 Feb 01; 41(2):134-40. PubMed ID: 18436489
    [Abstract] [Full Text] [Related]

  • 35. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
    Rew JS.
    Korean J Gastroenterol; 2006 Mar 01; 47(3):181-90. PubMed ID: 16554671
    [Abstract] [Full Text] [Related]

  • 36. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
    Hiyama T, Matsuo K, Urabe Y, Fukuhara T, Tanaka S, Yoshihara M, Haruma K, Chayama K.
    J Gastroenterol Hepatol; 2009 Aug 01; 24(8):1326-32. PubMed ID: 19702900
    [Abstract] [Full Text] [Related]

  • 37. Aging and upper gastrointestinal disorders.
    Pilotto A.
    Best Pract Res Clin Gastroenterol; 2004 Aug 01; 18 Suppl():73-81. PubMed ID: 15588798
    [Abstract] [Full Text] [Related]

  • 38. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J, Louis E, Persy V, Urbain D.
    Acta Gastroenterol Belg; 2013 Dec 01; 76(4):393-402. PubMed ID: 24592542
    [Abstract] [Full Text] [Related]

  • 39. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS.
    Eksp Klin Gastroenterol; 2010 Dec 01; (2):53-8. PubMed ID: 20496811
    [Abstract] [Full Text] [Related]

  • 40. Proton pump inhibitors for dyspepsia.
    Vakil N.
    Dig Dis; 2008 Dec 01; 26(3):215-7. PubMed ID: 18463438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.